New Japanese RCT Landmark Results: Exclusive Human Milk Diet Drives Superior Growth in Premature Infants Without Increased Safety Risks
Skip to main content
Resources & Evidence Contact us

Webinar: Human milk as therapy: Optimizing recovery and enteral autonomy for infants with gastroschisis

Sign Up for Webinar

Overview:

Explore the latest evidence on the use of an Exclusive Human Milk Diet (EHMD) for infants with gastroschisis. Join neonatologist Dr. Erin Hamilton Spence as she reviews the nutrition and growth challenges facing these vulnerable infants, examines emerging research on human milk-based nutrition, and discusses strategies to support optimal outcomes. The webinar also features a clinical case study presented by Dr. Craig Anderson, highlighting the nutritional management of a complex gastroschisis case.

Learning Objectives:

  • Review the nutrition and growth challenges for infants with gastroschisis
  • Interpret the evidence of an EHMD for infants with gastroschisis, small bowel atresia, and omphalocele
  • Explore Surgifort & strategies to meet nutritional goals
  • Discuss a specific case report for a complex gastroschisis case receiving Surgifort

Speakers:

  • Craig Anderson, DO, FAAP
    NICU Medical Director - Ascension St. John Medical Center
  • Erin Hamilton Spence MD, IBCLC, FAAP, FABM, NABBLM-C
    Senior Director of Clinical Education & Professional Development - Prolacta Bioscience


Disclaimer: The experiences, opinions, and results shared in this video reflect those of the speaker and do not necessarily represent the views of Prolacta. Certain statements, including referenced studies, are based on data that have been submitted to or evaluated by the U.S. Food and Drug Administration (FDA); however, other statements reflect the speaker’s interpretations and have not been reviewed by the FDA.

Dr Anderson received compensation from Prolacta for this presentation and provides additional services to the company.